|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBSCO_ocn835646204 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
130404s2012 nyu o 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d YDXCP
|d E7B
|d OCLCF
|d EBLCP
|d OCLCQ
|d D6H
|d VTS
|d TOF
|d AU@
|d STF
|d OCLCQ
|d K6U
|d OCLCQ
|d OCLCO
|d OCLCQ
|
020 |
|
|
|a 9781621008897
|q (electronic bk.)
|
020 |
|
|
|a 1621008894
|q (electronic bk.)
|
029 |
1 |
|
|a DEBBG
|b BV041049540
|
029 |
1 |
|
|a DEBBG
|b BV043775653
|
029 |
1 |
|
|a DEBSZ
|b 472781405
|
035 |
|
|
|a (OCoLC)835646204
|
050 |
|
4 |
|a R850
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Advances in medicine and biology.
|n Volume 43 /
|c Leon V. Berhardt, editor.
|
260 |
|
|
|a New York :
|b Nova Science Publishers,
|c ©2012.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Includes index.
|
588 |
0 |
|
|a Title page of PDF version (Ebsco; viewed on April 4, 2013).
|
505 |
0 |
|
|a ADVANCES IN MEDICINE AND BIOLOGY VOLUME 43; ADVANCES IN MEDICINE AND BIOLOGY VOLUME 43; Contents ; Preface ; Paralysis in ALS Patients Pathogenesis, Assessment and Treatment ; Abstract; Introduction ; Epidemiology ; Sporadic ALS ; Familial ALS ; Etiopathogenesis ; Genetic Factors ; Environmental Factors ; Excitotoxicity ; Oxidative Stress and Apoptosis ; Lack of Neurotrophic Factors ; Immune Events and Neuroinflammation ; Defective Autophagy ; Exogenous Toxicity ; Neuropathology ; Brain ; Brainstem ; Corticospinal Tract ; Spinal Cord ; Peripheral Nervous System; Muscle; Clinical Signs.
|
505 |
8 |
|
|a Clinical Features of Variant Disorders Diagnosis ; Clinical Criteria ; Neurophysiological Methods ; Conventional Electromyography ; Nerve Conduction Studies ; Transcranial Magnetic Stimulation ; Neuroimaging Techniques ; Laboratory Exams ; Muscle biopsy ; Biochemical Assays ; Differential Diagnoses ; Functional Assessment; Global Functional Scales ; The Appel ALS Rating Scale ; The ALS Severity Scale (ALSSS) ; ALS Functional Rating Scale ; Somatic Muscle Strength Assessment ; Manual Muscle Testing ; Maximal Voluntary Isometric Contraction ; Quantitative Electromyography.
|
505 |
8 |
|
|a Respiratory Muscle Function Assessment Swallowing Assessment ; Speech Assessment ; Treatment; Pathogenetic Treatment ; Neuropharmacological Strategies ; Excitotoxicity ; Oxidative Stress and Apoptosis ; Neurotrophic Factors ; Neuroinflammation ; Autophagy ; Neurobiological Strategies ; Gene Therapy; Stem Cell Therapy ; Neurophysiological Strategies ; Repetitive Transcranial Magnetic Stimulation ; Symptomatic Treatment ; Pharmacological Strategies ; Non Pharmacological Strategies ; Physical Exercise ; Respiratory Treatment; Respiratory Exercises ; Mechanical Ventilation.
|
505 |
8 |
|
|a Supportive Respiratory Care Swallowing Treatment ; Sialorrhea ; Speech Treatment ; Conclusion; References; Targeting Testosterone Pathways in Prostate Cancer Treatment ; Abstract ; Biology of Testosterone in Prostate Cancer ; 1. Androgen Synthesis and the Androgen Receptor Regulatory Pathway ; 2. Estrogen Receptors in Prostate Cancer ; 3. Prostate Cancer Prevention ; 1.) Finasteride ; 2.) Dutasteride; Androgen-Deprivation Therapy (ADT) ; 1.) Orchiectomy ; 2.) Estrogen; 3.) GnRH-A ; 4.) GnRH Antagonists ; 5.) Androgen Receptor Antagonists (ARAs) ; 6.) CYP17 Inhibitors; Ketoconazole.
|
505 |
8 |
|
|a Abiraterone Acetate TAK-700 (Orteronel) ; 7.) AR Antagonists ; MDV3100 ; BMS-641988 ; Small Molecule Modulators ; 8.) Dual CYP17 Inhibitor and AR Antagonist ; 9.) Glucocorticoids; 2. Early-Stage Prostate Cancer ; 1.) ADT as Primary Therapy ; 2.) ADT with Radiotherapy ; 3.) ADT with Brachytherapy ; 4.) ADT with Surgery ; 3. Metastatic Castration-Sensitive Disease ; 1.) Antiandrogen Monotherapy; 2.) Combined Androgen Blockade ; 3.) ADT with Chemotherapy ; 4.) ADT and Vaccine ; 4. Timing of ADT in Metastatic Castration-Sensitive Prostate Cancer ; 1.) Immediate vs. Deferred Therapy.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Clinical medicine.
|
650 |
|
0 |
|a Biology
|x Research.
|
650 |
|
2 |
|a Clinical Medicine
|
650 |
|
6 |
|a Médecine clinique.
|
650 |
|
6 |
|a Biologie
|x Recherche.
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Biology
|x Research.
|2 fast
|0 (OCoLC)fst00832448
|
650 |
|
7 |
|a Clinical medicine.
|2 fast
|0 (OCoLC)fst00864361
|
700 |
1 |
|
|a Berhardt, Leon V.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=535147
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3021392
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10683050
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 535147
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 7154523
|
994 |
|
|
|a 92
|b IZTAP
|